Stellantis (NYSE:STLA) reported 1.6 million estimated consolidated vehicle shipments for the second quarter of 2026, a 10% year-over-year increase. North American performance led the growth with a 38% ...

IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...

Coles (ASX:COL) raised the shelf price of its private-label milk range, citing a volatile global landscape that has sent operational costs for dairy farmers and logistics networks soaring. The ...

Hims & Hers (NYSE:HIMS) posted first-quarter revenue of $608.1 million, a 4% increase compared to $586 million in the prior-year period. However, the company’s gross margin fell to 65% from 73% a year ...

BSP Financial Group (ASX:BFL) has launched an investigation alongside leading external cyber experts following the detection of unauthorised third-party access to its back-office test environment. The ...

Inghams Group (ASX:ING) appointed Grant Douglas as its CFO, effective from October. Douglas, a veteran finance executive with over 25 years of international experience, joins the poultry giant ...

The federal government is checking if six foreign investors complied with orders to sell down their combined 17.58% stake in Northern Minerals. The immediate market impact remains unclear, as the ...

Personalis (NASDAQ:PSNL) unveiled comprehensive clinical data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, establishing the diagnostic capabilities of its ultrasensitive ...

ImmunityBio (NASDAQ:IBRX) announced positive results Tuesday from its ANKTIVA® clinical program, signaling a potential paradigm shift in the treatment of advanced non-small cell lung cancer (NSCLC) ...

United Therapeutics (NASDAQ:UTHR), a public benefit corporation, today announced that its pivotal TETON-1 study evaluating nebulized Tyvaso® (treprostinil) for the treatment of idiopathic pulmonary ...

Merck (NYSE:MRK) today reported fourth-quarter and full-year 2025 results that showcased a tale of two portfolios: a surging oncology and respiratory business set against a dramatic collapse in ...

Sea (NYSE:SE) announced first-quarter 2026 GAAP revenue of $7.1 billion, representing a 46.6% surge compared to the prior-year period. The company’s gross profit grew 40.7% to $3.1 billion, while net ...